Results 101 to 110 of about 1,126,910 (189)

Role of cyclooxygenase-2 inhibitors in the survival outcome of colorectal cancer patients: A population-based cohort study. [PDF]

Kaohsiung J Med Sci, 2017
Huang WW, Hsieh KP, Huang RY, Yang YH.
europepmc   +1 more source

Structure-activity relationships for the synthesis of selective cyclooxygenase 2 inhibitors: an overview (2009-2016). [PDF]

Medchemcomm, 2017
Carullo G, Galligano F, Aiello F.
europepmc   +1 more source

Propyphenazone-based analogues as prodrugs and selective cyclooxygenase-2 inhibitors. [PDF]

ACS Med Chem Lett, 2014
Radwan MF, Dalby KN, Kaoud TS.
europepmc   +1 more source

Using cyclooxygenase-2 inhibitors as molecular platforms to develop a new class of apoptosis-inducing agents.

Journal of the National Cancer Institute, 2002
Jiuxiang Zhu, Xueqin Song, Ho-pi Lin, D. Young, Shunqi Yan, V. Marquez, Ching S. Chen   +6 more
semanticscholar   +1 more source

Cardiovascular and cerebrovascular risk with nonsteroidal anti-inflammatory drugs and cyclooxygenase 2 inhibitors: latest evidence and clinical implications. [PDF]

Ther Adv Drug Saf, 2017
Fanelli A, Ghisi D, Aprile PL, Lapi F.
europepmc   +1 more source

Comparison of benefit-risk preferences of patients and physicians regarding cyclooxygenase-2 inhibitors using discrete choice experiments. [PDF]

Patient Prefer Adherence, 2016
Byun JH, Kwon SH, Lee JE, Cheon JE, Jang EJ, Lee EK.   +5 more
europepmc   +1 more source

Cyclooxygenase-2 inhibitors in ginger (Zingiber officinale).

Fitoterapia, 2011
R. V. van Breemen, Yi Tao, Wenkui Li
semanticscholar   +1 more source

The Spectrum of Gastrointestinal Toxicity and Effect on Disease Activity of Selective Cyclooxygenase-2 Inhibitors in Patients with Inflammatory Bowel Disease

Inflammatory Bowel Diseases, 2004
R. Matuk, J. Crawford, M. Abreu, S. Targan, E. Vasiliauskas, K. Papadakis   +5 more
semanticscholar   +1 more source

Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease. [PDF]

Cochrane Database Syst Rev, 2014
Miao XP, Li JS, Ouyang Q, Hu RW, Zhang Y, Li HY.   +5 more
europepmc   +1 more source

Cyclooxygenase-2 (COX-2) as a Potential Prognostic Marker in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. [PDF]

Health Sci Rep
Qasem HM, Odat RM, Alshwayyat S, Younis OM, Yasin JA, Hussein AM, Hammadeh BM, Ghlailat M, Amayreh LA, Yadav R, Nguyen D, Jain H, Kelkar R.   +12 more
europepmc   +1 more source